| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technology Officer &EVP | Chief Technology Officer | See Remarks +1 more
1 company
Aunins John G. is a Chief Technology Officer &EVP at Seres Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $695K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sell | 9,250 | $35.00 | $323,750.00 | -4.4% | |
| Jul 25, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sale+OE | 9,390 | $34.18 | $320,950.20 | -4.3% | |
| Jun 27, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sell | 9,390 | $27.23 | $255,689.70 | -22.3% | |
| May 31, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sell | 14,015 | $30.05 | $421,087.80 | -14.2% | |
| Apr 25, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sell | 18,640 | $31.94 | $595,361.60 | -25.0% | |
| Mar 28, 2016 | MCRB Seres Therapeutics, Inc. | Chief Technology Officer &EVP | Sell | 9,390 | $23.89 | $224,327.10 | -11.2% |